Synopsys Raises the Growth Bar at Investor Day as Wall Street Lifts Price Targets
Synopsys sees mid-teens revenue growth through 2030 and margins near 50%, while average analyst targets imply about 30% upside.
/ 8 items
#SNPS↓
Synopsys Signs $1B+ AWS Deal and OpenAI Pact to Speed Chip Design
Synopsys will supply custom chip IP to AWS and co-develop GPT-Synopsys with OpenAI. Shares rose after a higher 2027 growth outlook.
Mizuho Analyst Calls Cadence and Synopsys Dip a Buying Opportunity After Kimi K3 AI Chip Shock
Mizuho sees agentic AI tripling the EDA market and maintains Outperform ratings.
Why Elliott Just Bet Billions on Synopsys – And Wants More Money From Its Must-Have Software
Elliott Investment Management acquires multibillion-dollar stake in Synopsys to boost margins and monetization in the exploding AI chip sector.
Nvidia Dumps Stakes: Applied Digital, WeRide & Recursion Stocks Slide in After-Hours
Nvidia's latest 13F filing reveals it sold positions in Applied Digital, WeRide, and Recursion Pharmaceuticals in Q4 2025, causing after-hours dips.
GlobalFoundries Acquires Synopsys' Processor IP Business to Boost AI Chip Development
GlobalFoundries announces acquisition of Synopsys' ARC Processor IP Solutions to accelerate Physical AI development and expand RISC-V capabilities for next-gen applications.